Publications by authors named "Brigitte Widemann"

Claim this Profile
T
The spectrum of pathogenic NF1 variants in participants enrolling on clinical trials of MEK inhibitors for plexiform neurofibroma.
Chelsea Kotch, Alicia Gomes, Krista S Schatz, Eva Dombi, Symone Brown, Brigitte Widemann

Hum Genet· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Building Pediatric Cancer Cohorts and Accessing Data Using Childhood Cancer Data Initiative Tools.
Subhashini Jagu, Jaime M Guidry Auvil, Mark Cunningham, Bahar Sayoldin, Patrick Dunn, Brigitte Widemann

JCO Clin Cancer Inform· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Trends in Childhood and Adolescent Cancer Incidence Rates in the United States between 2001 and 2022.
Meredith S Shiels, Anika T Haque, Rena R Jones, Cari M Kitahara, John W Glod, Brigitte C Widemann

Cancer Discov· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Prostate is a Common Site of Disease in Patients with MEN2B and Medullary Thyroid Carcinoma.
Ira L Kraft, Srivandana Akshintala, Andrea Gross, Eva Dombi, Baris Turkbey, Brigitte C Widemann

Endocr Relat Cancer· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
How to foster new treatment development in ultra-rare tumours? Joint EMA-EORTC multi-stakeholder workshops on ultra-rare sarcomas as a model for rare cancers.
Silvia Stacchiotti, Pan Pantziarka, Hugh Leonard, Caroline Voltz, Laura Abatedaga, Brigitte Widemann

Cancer Treat Rev· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The impact of focused federal initiatives on pediatric cancer research.
Subhashini Jagu, Malcolm A Smith, Nita L Seibel, Emily S Tonorezos, Brigitte C Widemann

Cancer· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term Ocular Safety in Children Treated with Mitogen-Activated Protein Kinase Pathway Inhibitor Therapy.
Robert A Avery, Andrea M Gross, Chantal Cousineau-Krieger, Tiarnán D L Keenan, Taylor McManus, Brigitte C Widemann

Ophthalmology· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Investigating fatigue in adults with neuroendocrine neoplasms using a biopsychosocial model.
Sarah W Peters, Pamela L Wolters, Jaydira Del Rivero, Mary Frances Wedekind, Karlyne M Reilly, Brigitte Widemann

Support Care Cancer· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Whole Body-MRI assessment of peripheral lesions in patients with NF2-related schwannomatosis on systemic bevacizumab.
Shivani Ahlawat, Patrick Debs, Laura M Fayad, Scott R Plotkin, Brigitte C Widemann

J Neurooncol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinicopathologic Features, Management, and Outcomes Of Pediatric CRTC1::TRIM11 and MED15::ATF1 Tumors With Spitzoid Morphology: A Case Series.
Michael R Sargen, Madeline H Fitzhugh, Jennifer S Ko, Allison G Close, Sara C Horton, Brigitte Widemann

Pediatr Blood Cancer· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of the Notch ligand DLK1 as an immunotherapeutic target and regulator of tumor cell plasticity and chemoresistance in adrenocortical carcinoma.
Nai-Yun Sun, Suresh Kumar, Yoo Sun Kim, Diana Varghese, Arnulfo Mendoza, Brigitte Widemann

Nat Commun· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anthropometric measurements of children with neurofibromatosis type I: impact of plexiform neurofibroma volume and treatment.
Kathryn M Lemberg, Andrea M Gross, Lauren M Sproule, David J Liewehr, Eva Dombi, Brigitte C Widemann

Pediatr Res· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vincristine Sulfate Liposome Injection With Combination Chemotherapy for Children, Adolescents, and Young Adults With Relapsed Acute Lymphoblastic Leukemia: A Therapeutic Advances in Childhood Leukemia and Lymphoma Consortium Trial.
Nirali N Shah, Eric S Schafer, Yueh-Yun Chi, Jemily Malvar, Kenneth M Heym, Brigitte C Widemann

Pediatr Blood Cancer· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Challenges in Assessing Response in Clinical Trials for Neurofibromatosis Type 1 Plexiform Neurofibromas.
Eva Dombi, Andrea M Gross, Brigitte C Widemann, Brian D Weiss, Scott R Plotkin

J Clin Oncol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Selumetinib in pediatric patients with neurofibromatosis type 1 and plexiform neurofibroma: Propensity score analysis of SPRINT vs. natural history control arm.
Ayo Adeyemi, Andrea M Gross, Andrea Baldwin, Eva Dombi, Brigitte C Widemann

Neurooncol Adv· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk of carcinomas among children and adolescents with birth defects.
Jeremy M Schraw, Ji Yun Tark, Tania A Desrosiers, Tiffany M Chambers, Charles J Shumate, Brigitte C Widemann

Cancer Epidemiol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Parent-child discrepancies in reports of child psychosocial functioning in neurofibromatosis type 1.
Nour Al Ghriwati, Paige Little, Staci Martin, Mary Anne Tamula, Brigitte C Widemann

J Fam Psychol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Advances in pediatric oncology through collaborations.
Brigitte C Widemann

Curr Opin Pediatr· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of Cutaneous Neurofibromas in Neurofibromatosis Type 1 With MEK Inhibitor Selumetinib: A Nonrandomized Clinical Trial.
Andrea M Gross, Olivia H Reid, Lauren A Baldwin, Ashley Cannon, Hyoyoung Choo-Wosoba, Brigitte C Widemann

JAMA Dermatol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Selumetinib in adults with NF1 and inoperable plexiform neurofibroma: a phase 2 trial.
Andrea M Gross, Geraldine O'Sullivan Coyne, Eva Dombi, Cecilia Tibery, William G Herrick, Brigitte C Widemann

Nat Med· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Mixed Methods Study of Medication Adherence in Adults with Neurofibromatosis Type 1 (NF1) on a Clinical Trial of Selumetinib.
Millicent S Curlee, Mary Anne Toledo-Tamula, Melissa Baker, Daniel Wikstrom, Cynthia Harrison, Brigitte C Widemann

Cancers (Basel)· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Update on Pediatric Cancer Surveillance Recommendations for Patients with Neurofibromatosis Type 1, Noonan Syndrome, CBL Syndrome, Costello Syndrome, and Related RASopathies.
Melissa R Perrino, Anirban Das, Sarah R Scollon, Sarah G Mitchell, Mary-Louise C Greer, Brigitte C Widemann

Clin Cancer Res· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early Detection of Malignant and Premalignant Peripheral Nerve Tumors Using Cell-Free DNA Fragmentomics.
R Taylor Sundby, Jeffrey J Szymanski, Alexander C Pan, Paul A Jones, Sana Z Mahmood, Brigitte C Widemann

Clin Cancer Res· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of DLK1, a Notch ligand, as an immunotherapeutic target and regulator of tumor cell plasticity and chemoresistance in adrenocortical carcinoma.
Nai-Yun Sun, Suresh Kumar, Yoo Sun Kim, Diana Varghese, Arnulfo Mendoza, Brigitte Widemann

bioRxiv· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Platform trial design for neurofibromatosis type 1, NF2-related schwannomatosis and non-NF2-related schwannomatosis: A potential model for rare diseases.
Britt A E Dhaenens, Günter Heimann, Annette Bakker, Marco Nievo, Rosalie E Ferner, Brigitte C Widemann

Neurooncol Pract· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis